Navigation Links
Amrubicin in Medical News

Small-Cell Lung Cancer Drug Market Will More Than Double to Over $684 Million in 2017

... of Genentech/Roche/Chugai's Avastin and Celgene's amrubicin (currently marketed in Japan as Calsed by Nippon K...s a first-line add-on to standard chemotherapy and amrubicin as a second-line therapy will drive robust 22 perc...ore, despite the impressive sales that Avastin and amrubicin will add to the market, these therapies will have ...

Amrubicin Shows Encouraging Results for Small Cell Lung Cancer Treatment

...n terms of response rate and safety when comparing amrubicin to the current treatment standard, topotecan, in s...mall cell lung cancer." The trial compares amrubicin and topotecan in patients with ED-SCLC that initia... participants are randomized 2:1 to receive either amrubicin (40 mg/m2 via 5- min.infusion daily x 3 days) or t...
Amrubicin in Medical Technology

Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer

Interim analysis of Phase 2 clinical data presented at the 2007 Chemotherapy Foundation Symposium BOULDER, Colo., Nov. 9 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM ) today released interim findings from its Phase 2 trial of Amrubicin in second-line chem...

Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer

BOULDER, Colo., Oct. 17 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM ) today announced the initiation of an international pivotal Phase 3 clinical trial evaluating amrubicin, the Company's third-generation synthetic anthracycline, in the treatment of second-line small cell lun...

Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer

Interim Analysis of Phase 2 Clinical Data Published at the American Society of Clinical Oncology 43rd Annual Meeting CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Pharmion Corporation today released interim findings from its Phase II, multi-center clinical study of Amrubicin, the company's thir...

Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting

...ate Cancer." Interim data on a Phase II study of amrubicin appears in the ASCO 2007 conference publication, a... June 4, 2007; 11:00-11:15am; Arie Crown Theater amrubicin A randomized phase II trial of amrubicin vs. Topotecan as second-line treatment in extensiv...
Other Tags
(Date:9/2/2014)... The Jerry Segal Classic to benefit ... 19 at The ACE Club and Green Valley Country ... years, the Classic, organized by the Friends of Jerry ... and services designed to support patients and their families ... “The Segal Classic is a labor of love, my ...
(Date:9/2/2014)... Port Washington, New York (PRWEB) September 02, 2014 ... Waichman LLP announces that Class Counsel has ... and for service awards in the class action ... to Parker Waichman LLP, the Court-Appointed Class Counsel ... Cabraser Heimann & Bernstein, LLP; Audet & Partners, ...
(Date:9/2/2014)... 2014 Lseat.com is one of the most ... its products are user-friendly items; no professional installation is required. ... they can slip right over the cars’ seats. That can ... website is filled with various kinds of practical covers. ... of Jeep leather seat covers . Also, the company ...
(Date:9/2/2014)... California (PRWEB) September 02, 2014 The ... reach USD 8,918.8 million by 2020, growing at an ... to a new study by Grand View Research, Inc. ... and plague modification devices are used for treating peripheral ... formation of atherosclerotic plaques in arteries. These devices are ...
(Date:9/2/2014)... 2014 Eric Jimenez and Leah Ashley ... a revolutionary makeup application device. Designed to improve and ... in the palm of women’s hands to help them ... Color Me’s success lies in its patented technology. With ... of 15,000 pulses per minute, the device applies foundation ...
Breaking Medicine News(10 mins):Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 3Health News:High Quality 1997-2006 JEEP Wrangler TJ Leather Seat Covers From Popular Supplier Lseat.com 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3
(Date:9/1/2014)... decisions of the Nomenclature Section of the XVIII International ... 2011. This meeting is held every six years and ... rules for naming algae, fungi and plants get together ... the organisms they study. This is the primary product ... algae, fungi, and plants, which was published in 2012. ...
(Date:8/31/2014)... fast and accurate tool to diagnose tuberculosis in ... developed test (TAM-TB assay) is the first reliable ... The test features excellent specificity, a similar sensitivity ... a blood test. The promising findings are a ... children, particularly in tuberculosis-endemic regions. , The study ...
(Date:8/31/2014)... of the greatest challenges in modern medicine is developing ... with minimal toxicity and side-effects to the patient. Such ... the drug molecule. Ideally, the drug should have a ... so that it binds it with high specificity. Publishing ... a synthetic amino acid that can impact the 3D ...
Breaking Biology News(10 mins):Week-long meeting on naming algae, fungi, and plants recorded for posterity 2New tuberculosis blood test in children is reliable and highly specific 2A new synthetic amino acid for an emerging class of drugs 2A new synthetic amino acid for an emerging class of drugs 3
Other Contents